Pamela L. Kunz, MD

Pamela L. Kunz, MD, is an associate professor of internal medicine and chief of the Division of Gastrointestinal Medical Oncology, Section of Medical Oncology, at Yale School of Medicine. She is also director of the Center for Gastrointestinal Cancers at Smilow Cancer Hospital and Yale Cancer Center. She completed her residency in internal medicine and fellowship training in oncology at Stanford University School of Medicine.

Dr Kunz is a medical oncologist and an international leader in the treatment and clinical research of patients with gastrointestinal (GI) malignancies and neuroendocrine tumors (NETs). She holds several leadership positions in the field, including President Emeritus of the North American Neuroendocrine Tumor Society (NANETS), recent past chair of the National Cancer Institute Neuroendocrine Tumor Task Force, and member of the US Food and Drug Administration's Oncologic Drugs Advisory Committee. Dr Kunz also serves on the NANETS Executive Committee and Board of Directors. She is currently the editor in chief of JCO Oncology Advances.

In addition to her focus on NETs, Dr Kunz is a leading voice for promoting diversity, equity, and inclusion in medicine. She served as vice chief of Diversity, Equity, and Inclusion for the Section of Medical Oncology at Yale School of Medicine and, in 2021, was named "Woman Oncologist of the Year" by Women Leaders in Oncology for her work in promoting gender equity.